4,150 Shares in Waters Co. (NYSE:WAT) Bought by one8zero8 LLC

one8zero8 LLC acquired a new position in shares of Waters Co. (NYSE:WAT) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 4,150 shares of the medical instruments supplier’s stock, valued at approximately $1,540,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Bank of Jackson Hole Trust purchased a new stake in shares of Waters during the fourth quarter worth $34,000. Fortitude Family Office LLC raised its holdings in shares of Waters by 235.7% during the fourth quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier’s stock worth $35,000 after acquiring an additional 66 shares in the last quarter. Steward Partners Investment Advisory LLC raised its holdings in shares of Waters by 129.3% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 94 shares of the medical instruments supplier’s stock worth $35,000 after acquiring an additional 53 shares in the last quarter. EverSource Wealth Advisors LLC raised its holdings in shares of Waters by 54.3% during the fourth quarter. EverSource Wealth Advisors LLC now owns 125 shares of the medical instruments supplier’s stock worth $46,000 after acquiring an additional 44 shares in the last quarter. Finally, R Squared Ltd purchased a new stake in shares of Waters during the fourth quarter worth $63,000. 94.01% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several analysts recently issued reports on WAT shares. Wells Fargo & Company increased their price objective on Waters from $415.00 to $420.00 and gave the stock an “overweight” rating in a report on Thursday, February 13th. StockNews.com downgraded shares of Waters from a “buy” rating to a “hold” rating in a research report on Tuesday, February 25th. Barclays raised shares of Waters from an “underweight” rating to an “equal weight” rating and increased their target price for the stock from $360.00 to $415.00 in a research report on Monday, February 10th. UBS Group increased their target price on shares of Waters from $405.00 to $410.00 and gave the stock a “neutral” rating in a research report on Thursday, February 13th. Finally, Sanford C. Bernstein raised shares of Waters from a “market perform” rating to an “outperform” rating and set a $430.00 target price on the stock in a research report on Friday, January 10th. Eleven investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $391.07.

Waters Trading Up 3.8 %

Shares of NYSE:WAT opened at $378.18 on Friday. The company has a market cap of $22.47 billion, a P/E ratio of 35.31, a P/E/G ratio of 3.79 and a beta of 1.00. The stock’s 50-day moving average is $391.24 and its 200-day moving average is $370.28. Waters Co. has a 52-week low of $279.24 and a 52-week high of $423.56. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.65 and a current ratio of 0.94.

Waters (NYSE:WAT) last released its earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share for the quarter, topping analysts’ consensus estimates of $4.02 by $0.08. Waters had a return on equity of 46.31% and a net margin of 21.56%. Equities research analysts predict that Waters Co. will post 12.86 earnings per share for the current year.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.